Hepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and meta-analysis
Open Access
- 9 October 2024
- journal article
- research article
- Published by Elsevier in JHEP Reports
- Vol. 7 (1) , 101227
Abstract
No abstract availableKeywords
Funding Information
- Association Française pour l'Etude du Foie
- NIHR (ALPINE NIHR 155210)
This publication has 47 references indexed in Scilit:
- The Natural History of Advanced Chronic Liver Disease Defined by Transient ElastographyClinical Gastroenterology and Hepatology, 2022
- Validation of the aMAP score to predict hepatocellular carcinoma development in a cohort of alcohol‐related cirrhosis patientsLiver Cancer International, 2022
- Long‐term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e‐antigen seroclearanceHepatology, 2018
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology, 2018
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National LevelJAMA Oncology, 2017
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 updateHepatology International, 2017
- Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)Hepatology, 2016
- Prediction of development of hepatocellular carcinoma using a new scoring system involving virtual touch quantification in patients with chronic liver diseasesJournal of Gastroenterology, 2016
- The clinical course of cirrhosis: The importance of multistate models and competing risks analysisHepatology, 2015
- Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS‐HCC risk modelCancer, 2014